Of these, 422 developed biochemical recurrence (PSA > 0.2 ng/mL) and were managed with surveillance until time of metastasis, which eventually occurred in 123 patients; 41 died of prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.